バリシチニブが中枢神経系の炎症性脱髄疾患を引き起こした症例報告
Rozita Khalili1,2, Ahmad A Toubasi2, Meryim Poursheykhi3
1Neuroimmunology Division, Department of Neurology, University of Tennessee Health Science Center (UTHSC), Memphis, TN, USA.
バリシチニブなどのヤヌスキナーゼ阻害剤(JAKi)は、炎症を抑制する可能性がありますが、中枢神経系(CNS)の脱髄疾患を引き起こす可能性があります。この症例は、バリシチニブがCNSの炎症を悪化させる潜在的なリスクを強調しており、患者の注意深いモニタリングが必要です。
さらに関連する動画
11:51Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
Published on: August 16, 2010
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
関連する概念動画
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
What is a Nervous System?
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Measures of Central Tendency
